These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5317563)

  • 1. [Initial clinical experiences with the administration of new amino acid derivatives in the treatment of malignant tumors].
    Eder J; Zangger J
    Krebsarzt; 1969; 24(6):364-9. PubMed ID: 5317563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent clinical experiences in the treatment of solid tumors with Peptichemio alone or in combination].
    Paparopoli G
    G Ital Chemioter; 1974; 21(1):33-5. PubMed ID: 4619385
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
    Berman E; Casper ES; Howard J; Wittes RE
    Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors.
    Silver BA; Barlock AL; Lippman ME; Anderson T; Fisher RI
    Cancer Treat Rep; 1982 May; 66(5):1229-30. PubMed ID: 6211231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prediction of the individual chemosensitivity of human malignant tumors: the biological patterns and clinical results].
    Chissov VI; Sergeeva NS; Borisov VI; Skotnikova OI; Sviridova IK
    Eksp Klin Farmakol; 1995; 58(1):11-5. PubMed ID: 7787684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor stem cell clonogenic assay sensitivity in malignant tumors and clinical correlation.
    Banerjee TK; Marx JJ; Spencer SK; Tiffany E
    Wis Med J; 1982 Dec; 81(12):19-22. PubMed ID: 6760565
    [No Abstract]   [Full Text] [Related]  

  • 8. On the genesis and regulation of cellular heterogeneity in malignant tumors.
    Poste G; Greig R
    Invasion Metastasis; 1982; 2(3):137-76. PubMed ID: 6765249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS; Mackel C; Pocelinko R; Salmon SE
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
    Cancer Clin Trials; 1980; 3(2):115-20. PubMed ID: 7428135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amino acids, their derivatives and peptides in cancer chemotherapy].
    Krepelka J
    Cesk Farm; 1983 Mar; 32(2):76-87. PubMed ID: 6342820
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of the modern chemotherapy of tumors].
    Garin AM; Perevoschikova NI
    Vestn Akad Med Nauk SSSR; 1982; (12):55-60. PubMed ID: 7157992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood amino acid composition of bronchial asthma patients undergoing therapy with immunodepressants and cytostatics].
    Goguev NT
    Ter Arkh; 1984; 56(9):85-7. PubMed ID: 6515553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combinations drug therapy in solid tumors].
    Madrigal PL; Pérez Manga S; Pérez Gómez FJ
    Acta Oncol (Madr); 1975 May; 10(2):101-8. PubMed ID: 1211112
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas.
    Burris HA; Hurwitz HI; Dees EC; Dowlati A; Blackwell KL; O'Neil B; Marcom PK; Ellis MJ; Overmoyer B; Jones SF; Harris JL; Smith DA; Koch KM; Stead A; Mangum S; Spector NL
    J Clin Oncol; 2005 Aug; 23(23):5305-13. PubMed ID: 15955900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II-III- study of cis-diaminodichloroplatinum (cisplatinum) (author's transl)].
    Cortés-Funes H; Moyano A
    Med Clin (Barc); 1981 May; 76(9):388-95. PubMed ID: 7017298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effects of p-aminobenzoic acid-N-xyloside Na--effects of single administration and combination with radiotherapy].
    Fukushima M; Ota K
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):230-7. PubMed ID: 6985191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.